UCP1 and obesity disorder: Moreover, our in vivo experiment results confirmed that SFN treatment substantially decreased the adipocyte size and body weight gain, and further prevented HFD-induced obesity through the browning of adipocytes via mitochondrial biogenesis and the activation of Ucp1 and Pgc1-α.